Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).

 

To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:

Type of Repurposing Approaches

Disease-centric approach

Target-centric approach

Drug-centric approach

Therapeutic Area

Same Therapeutic Area

Different Therapeutic Area

Type of Drug Molecule

Biologics

Small Molecule

Key Geographical Region

North America

Europe

Asia-Pacific

 

The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 

Auxillis Pharma

ChemBio Discovery Solutions

Excelra

GVK Bio

Iris Pharma

Lantern Pharma

PanXome

Pharmacelera

Physiogenex

Smart Pharma

Socium

SOM Biotech

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Role of Non-Profit / Academic Organizations

 

6. Company Profiles 

7. Partnerships 

8. Big Pharma Initiatives 

9. Case Study: Discontinued Drug Development Programs

10. Cost Saving Analysis

11. Market Forecast and Opportunity Analysis

12.  Covid-19 Impact on Drug Repurposing Service Providers Market

 

13. Recent Advancements and Trends in Outsourcing of Drug Repurposing

 

 

 

14. Interview Transcripts

  

15. Appendix 1: List of Potential Drug-Indication Candidates for Drug Repurposing

  

16. Appendix 2: Tabulated Data

  

17. Appendix 3: List of Companies and Organizations

 

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

 

 

Contact Details

 

Gaurav Chaudhary

 

+1 (415) 800 3415

 

gaurav.chaudhary@rootsanalysis.com 

 

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe